Results 201 to 210 of about 18,714 (246)
Some of the next articles are maybe not open access.

Sweat Glands Accumulate Tc-99m MIBI

Clinical Nuclear Medicine, 1996
Tc-99m MIBI, which was originally developed for myocardial perfusion studies, may also be used for depiction and characterization of tumors. Forty-one patients with suspected hyperparathyroidism were examined with Tc-99m MIBI to localize a parathyroid adenoma or hyperplasia. In 19 of these patients (46%), bilateral symmetrical activity corresponding to
C, Jonsson   +3 more
openaire   +2 more sources

Noncardiac uptake of technetium-99m MIBI

Seminars in Nuclear Medicine, 1994
A 74-YEAR-OLD spanish-speaking Peruvian woman underwent total thyroidectomy with bilateral median neck dissection in 1977 for follicular thyroid carcinoma. This was followed by Iodine-131 (1311) ablation for remnant thyroid tissue. In 1987, a 131I whole-body scan and a computed tomography scan of the chest confirmed lung metastasis as well as ...
C W, Sutter, M J, Joshi, R C, Stadalnik
openaire   +2 more sources

Tc-99m MIBI Accumulation in Myositis Ossificans

Clinical Nuclear Medicine, 1998
A 52-year-old man who had a history of trauma after a fall 8 years before reported pain in the right knee for 5 or 6 weeks. Roentgenographs and three-phase bone scintigraphy were performed 1 month earlier and myositis ossificans was suspected. Because the patient had continuous knee pain, a Tc-99m MIBI scan was performed to evaluate a possible tumor in
Sarikaya, A   +6 more
openaire   +2 more sources

Accumulation of99mTc-MIBI in bone marrow

Annals of Nuclear Medicine, 1996
99mTc-MIBI (Sestamibi) was originally developed for myocardial perfusion studies. The agent also may be used for the depiction and characterization of tumors. Performing such examinations has shown uptake in skeletal structures in several patients suggesting bone engagement of the disease which later was excluded.
C, Jonsson, H, Jacobsson
openaire   +2 more sources

Gated 99Tcm-cm-MIBI myocardial function imaging

Nuclear Medicine Communications, 1991
The introduction of the 99Tcm isonitrile perfusion agents has provided improved myocardial image quality with conventional imaging equipment allowing improved edge definition on gating. We evaluated left ventricular wall motion in 46 patients using gated 99Tcm-2-methoxy-2-methyl-isopropyl-1-isonitrile (MIBI) scintigraphy.
P G, Avery   +4 more
openaire   +2 more sources

99mTc-MIBI myocardial perfusion imaging in myocarditis

Nuclear Medicine Communications, 2003
Myocardial perfusion imaging with technetium-99m-labelled methoxyisobutyl isonitrile single photon emission computed tomography (99mTc-MIBI SPECT) has proven to be an important clinical procedure in assessing the severity of myocardial ischaemia.
Y, Sun   +8 more
openaire   +2 more sources

Tc-99m MIBI Scintigraphy in Multiple Myeloma

Clinical Nuclear Medicine, 2010
Technetium-99m 2 methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy has been used to identify biologic activity and extent of multiple myeloma (MM) and monoclonal gammopathy of unknown significance (MGUS). The examination could also serve both as a prognostic tool and an examination for monitoring the disease course in MM patients.
Jaroslav, Bacovsky   +7 more
openaire   +2 more sources

MIBI-Szintigrafie bei hypofunktionellen Schilddrüsenknoten

Der Nuklearmediziner, 2016
Tc-99m-MIBI ist ein nicht spezifisches Radiopharmakon zur Tumordiagnostik und wurde historisch zum Nachweis radioiodnegativer Metastasen differenzierter Schilddrusenkarzinome eingesetzt, eine Indikation, die heutzutage durch FDG-PET ersetzt ist. Tc-99m-MIBI hat einen klinischen Nutzen zur Abklarung hypofunktioneller Schilddrusenknoten, wenngleich ...
openaire   +1 more source

Tc-99m MIBI imaging in malignant fibrous histiocytoma

Annals of Nuclear Medicine, 2001
The authors report a case of malignant fibrous histiocytoma of the left forearm demonstrated by Tc-99m MIBI imaging. The tumor originated in the soft tissue of the forearm; no obvious bone invasion or metastasis was detected scintigraphically or radiologically.
Berk, F, Ercin, C, Demir, H, Aktolun, C
openaire   +3 more sources

MIBI as prognostic factor in breast cancer.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003
Evaluation of treatment response is of primary importance in the management of patients with cancer. Both positron- and g-emitting compounds have been used to monitor changes in tumor metabolism or viability after therapy. The use of (99m)Tc-labeled lipophilic cations raised the possibility to predict the tumor response to treatment and to identify ...
DEL VECCHIO, SILVANA   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy